ATLASATLAS fair value
ATLAS has no fair value for this stock today.
Myomo (MYO)
Myomo stock price today, ATLAS forecast and fair value
Healthcare · Medical Devices · NYSE
$1.17▼ -2.50%
Prices as of Oct 27, 2026 · USD
Chance of rising in 1 month
46%
that it ends higher than today in 21 sessions
0%coin flip 50%100%
This is just the summary. See everything on Myomo in ATLAS
ATLAS's own quantitative analysis, all in one place.
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
See everything included
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
On Myomo
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
And for you
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
Plans from €3.99 a month.
ATLAS's model gives Myomo a 46% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between $1.00 and $1.31; in 9 out of 10, between $0.79 and $1.66. Estimated annual volatility is 75%.
Price, last 12 months (weekly close)
Key numbers
- Market cap
- $64.6M
- 52-week high
- $1.89
- 52-week low
- $0.61
- Revenue (12 months)
- $43.3M
- Revenue growth (YoY)
- +25.7%
- Gross margin
- 65.7%
- Operating margin
- -35.2%
- Net margin
- -38.1%
- Return on equity
- -123.8%
- Free cash flow (12 months)
- $-2.4M
- Beta
- 1.50
What this means
ATLAS does not publish a fair value for MYO right now, but it does show its odds of rising: close to a coin flip.
Over the last 52 weeks MYO has traded between $0.61 and $1.89. Today it is 37.9% below that high and 92% above its low.
On the business: revenue grew 25.7% year over year; net margin is 38.1%.
Its beta is 1.50: it tends to move more than the market, both up and down.
About the company
Myomo Inc. is a medical robotics company that develops and markets myoelectric orthotic devices for people with neuromuscular disorders and upper-limb paralysis.
Want to see everything about Myomo?
Get started →Plans from €3.99 a month.
Comparable companies
Other companies in the same line of business:
Frequently asked questions
What does Myomo do?
Myomo Inc. is a medical robotics company that develops and markets myoelectric orthotic devices for people with neuromuscular disorders and upper-limb paralysis.
What is the chance MYO goes up next month?
46%: close to a coin flip. In half of the simulated outcomes, MYO ends the month between $1.00 and $1.31.
How big is Myomo and what is its P/E ratio?
Myomo's market capitalization is $64.6M. We do not show a P/E because it has no positive earnings to base one on.
How volatile is MYO?
ATLAS estimates annual volatility at 75%. In a typical month, half of the outcomes end between $1.00 and $1.31.
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer